TEIKOKU PHARMA USA

Serial Number 85352277
Registration 4083988
800

Registration Progress

Application Filed
Jun 21, 2011
Under Examination
Approved for Publication
Oct 25, 2011
Published for Opposition
Oct 25, 2011
Registered
Jan 10, 2012

Trademark Image

TEIKOKU PHARMA USA

Basic Information

Serial Number
85352277
Registration Number
4083988
Filing Date
June 21, 2011
Registration Date
January 10, 2012
Published for Opposition
October 25, 2011
Renewal Date
January 10, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
800
Status Date
Apr 27, 2021
Registration
Registered
Classes
042

Rights Holder

TEIKOKU PHARMA USA, INC.

03
Address
1718 Ringwood Avenue
San Jose, CA 95131

Ownership History

TEIKOKU PHARMA USA, INC.

Original Applicant
03
San Jose, CA

TEIKOKU PHARMA USA, INC.

Owner at Publication
03
San Jose, CA

TEIKOKU PHARMA USA, INC.

Original Registrant
03
San Jose, CA

Legal Representation

Attorney
Bret E. Field

USPTO Deadlines

Next Deadline
2188 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20120110)
Due Date
January 10, 2032
Grace Period Ends
July 10, 2032

Application History

33 events
Date Code Type Description Documents
Apr 27, 2021 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Apr 27, 2021 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Apr 27, 2021 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Apr 27, 2021 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 14, 2021 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Jan 10, 2021 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Dec 21, 2017 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Dec 21, 2017 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Dec 19, 2017 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Nov 27, 2017 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jan 9, 2017 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 10, 2017 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jan 10, 2012 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 25, 2011 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 25, 2011 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 21, 2011 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Sep 15, 2011 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 13, 2011 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 13, 2011 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 13, 2011 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Sep 13, 2011 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Sep 13, 2011 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Sep 12, 2011 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Aug 29, 2011 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Aug 24, 2011 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 22, 2011 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 22, 2011 ALIE A ASSIGNED TO LIE Loading...
Aug 22, 2011 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 22, 2011 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Aug 22, 2011 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 15, 2011 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 29, 2011 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 24, 2011 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical research and development
First Use Anywhere: Dec 31, 2010
First Use in Commerce: Dec 31, 2010

Additional Information

Translation
The English translation of "TEIKOKU" in the mark is EMPIRE.

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA USA"